Status:
TERMINATED
Safety of Dialysate Sodium Individualization in Hemodialysis Patients With Intradialytic Hypotension
Lead Sponsor:
Yale University
Conditions:
Hemodialysis
Hypotension
Eligibility:
All Genders
18-90 years
Phase:
PHASE1
Brief Summary
Low blood pressure (hypotension) during dialysis afflicts approximately 25% of hemodialysis patients. In this pilot study, we will evaluate the safety and effects of individualizing the sodium concent...
Detailed Description
Hypertension and intradialytic hypotension are common complications in patients on chronic maintenance hemodialysis (HD). Sodium balance is important in mediating both processes. Recent evidence shows...
Eligibility Criteria
Inclusion
- Hemodialysis patients with intradialytic hypotension
Exclusion
- Atrial fibrillation
- Bilateral upper extremity arteriovenous access
- Average plasma sodium \>139
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT00237783
Start Date
October 1 2005
End Date
October 1 2008
Last Update
July 26 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Connecticut Healthcare System
West Haven, Connecticut, United States, 06516